Kirkland & Ellis advised AbbVie, Latham & Watkins advised Cerevel Therapeutics, Skadden advised Centerview partners LLC, as financial advisor to Cerevel Therapeutics in the transaction. AbbVie...
You must be a Standard 1 Year member to access this content.
Latham & Watkins advised NextGen Healthcare, Goodwin Procter advised Thoma Bravo, and Skadden advised Morgan Stanley & Co. LLC as financial advisor to NextGen Healthcare on...
You must be a Standard 1 Year member to access this content.
Latham & Watkins advises Tapestry, Inc. in the acquisition of Capri Holdings advised by Wachtell, Lipton, Rosen & Katz. Tapestry, Inc. (NYSE: TPR), a house of...
You must be a Standard 1 Year member to access this content.
Latham & Watkins advises H2B2, while Skadden and Pérez-Llorca advise RMG III. H2B2 Electrolysis Technologies, Inc. and RMG Acquisition Corp. III (Nasdaq: RMGC), a publicly-traded special purpose...
You must be a Standard 1 Year member to access this content.
Cooley advised Geron, while Latham & Watkins represented the underwriters in the offering. Geron Corporation (Nasdaq: GERN), a late-stage clinical biopharmaceutical company, has announced the pricing...
You must be a Standard 1 Year member to access this content.
